North American Neuroendocrine Tumor Society

North American Neuroendocrine Tumor Society Dedicated to supporting outcomes for NET patients through multidisciplinary medical education, research, publication of guidelines, and innovation.

Dr. Jennifer Chan shares the latest advances in neuroendocrine cancer — including FDA & EMA approvals of cabozantinib an...
11/24/2025

Dr. Jennifer Chan shares the latest advances in neuroendocrine cancer — including FDA & EMA approvals of cabozantinib and belzutifan — plus exciting ongoing trials like COMPETE and alpha-emitting PRRT.

Watch the full interview: https://loom.ly/ZptiqcI

Keep up with NANETS! Our newsletter delivers the latest on neuroendocrine tumor (NET) research, clinical guidelines, pro...
11/20/2025

Keep up with NANETS! Our newsletter delivers the latest on neuroendocrine tumor (NET) research, clinical guidelines, professional opportunities, and member highlights — your go-to source for all things NET.

Subscribe now: https://loom.ly/mErILxM

Patients, caregivers, and healthcare professionals are invited to take part in SCAN 2025 — the Survey of Challenges in A...
11/18/2025

Patients, caregivers, and healthcare professionals are invited to take part in SCAN 2025 — the Survey of Challenges in Access for Diagnostics and Treatment for NET Patients.

Available in 15 languages, this global survey gathers vital insights to improve access to diagnosis, treatment, and care worldwide.

🗓️ Share your voice by November 30, 2025.

Take the survey today: https://loom.ly/wiiQVYY

Mayo Clinic Gastrointestinal Oncologist Dr. Jason Starr sits down with Lisa Yen (LACNETS) and Stephanie Alband (INCA & T...
11/12/2025

Mayo Clinic Gastrointestinal Oncologist Dr. Jason Starr sits down with Lisa Yen (LACNETS) and Stephanie Alband (INCA & The PheoPara Alliance) — leaders in neuroendocrine and rare cancer advocacy — to discuss how we’re Bridging the Gap for patient advocacy.

Tune in to hear powerful insights on collaboration, community, and the impact of patient voices in advancing care.

🎙️ Listen now: https://loom.ly/mnr2n0k

The incidence of neuroendocrine tumors (NETs) is rising, yet globally it takes 5 years on average from first symptoms to...
11/10/2025

The incidence of neuroendocrine tumors (NETs) is rising, yet globally it takes 5 years on average from first symptoms to diagnosis. Awareness is key to earlier detection and better outcomes.

This NET Cancer Day, join us in raising awareness of NET signs and symptoms — and help assess gaps in diagnostics and care worldwide by sharing the SCAN 2025 campaign. Patients, caregivers, and healthcare professionals are encouraged to take the survey and share their experiences.

Take action today: https://loom.ly/qieCY4w

From the 2025 INCA Global Summit in Sofia, Bulgaria — Dr. Jennifer Chan (Dana-Farber) and Dr. Jaydira Del Rivero (NCI, N...
11/06/2025

From the 2025 INCA Global Summit in Sofia, Bulgaria — Dr. Jennifer Chan (Dana-Farber) and Dr. Jaydira Del Rivero (NCI, NIH) discuss the future of neuroendocrine tumor (NET) research, highlighting the power of clinical trials, patient engagement, and global collaboration in driving progress.

Watch their full conversation: https://www.youtube.com/watch?v=Uazkml2dDrs

The Neuroendocrine Cancer Foundation was proud to participate in the 13th International Neuroendocrine Cancer Alliance (...
11/04/2025

The Neuroendocrine Cancer Foundation was proud to participate in the 13th International Neuroendocrine Cancer Alliance (INCA) Global Patient Advocate Summit in Sofia, Bulgaria.

As one of 30 representatives from over 25 INCA member organizations around the world, NCF joined global advocates to strengthen collaboration, raise awareness, and advance access to timely diagnosis, quality care, and research for neuroendocrine cancer.

Read more about this important effort: https://loom.ly/rrULpIs

10/30/2025

Nearly 7 in 100,000 people are diagnosed with NETs each year. Awareness and education are vital to improving detection and treatment.

Support the cause and help drive progress: 🔗 https://nanets.net/donate

We want to hear from YOU! Your voice is essential in guiding our advocacy efforts. Share your ideas, experiences, and fe...
10/28/2025

We want to hear from YOU! Your voice is essential in guiding our advocacy efforts. Share your ideas, experiences, and feedback.

📸 Send your stories & photos to staff@nanets.net
💬 Comment below or message us to join the conversation!

What an incredible Symposium! To our dedicated staff, generous sponsors, valued community partners, and every attendee w...
10/28/2025

What an incredible Symposium! To our dedicated staff, generous sponsors, valued community partners, and every attendee who made this year's NANETS Symposium unforgettable - thank you from the bottom of our hearts. Your passion, collaboration, and commitment to advancing NET care inspire us every single day. 💜

Save the Date!
✨ 2026 NANETS Symposium
📍 JW Marriott Las Vegas Resort & Spa
📅 November 5–7, 2026

🎙️The NETCast is going LIVE at NANETS Symposium! Join us for dynamic conversations with leading NET experts covering the...
10/25/2025

🎙️The NETCast is going LIVE at NANETS Symposium! Join us for dynamic conversations with leading NET experts covering the topics that matter most:

➡️ Hybrid Neuroendocrine Cancer
➡️ Latest NET Medicine Developments
➡️ AI in Healthcare
➡️ NET HOT Topics
➡️ Patient Advocacy

New episodes drop in the coming weeks! Catch up on previous episodes now on our website or Spotify, and don't miss the Symposium series.

This is what NANETS is all about. 💜 Day 2 of our symposium reminds us that beyond the research and presentations, we're ...
10/24/2025

This is what NANETS is all about. 💜 Day 2 of our symposium reminds us that beyond the research and presentations, we're a family united by a common mission. The connections made, the conversations shared, and the support we give one another - that's the heart of our community. Thank you for showing up, not just for the science, but for each other.

Address

136 Everett Road
Albany, NY
12205

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+13603144112

Website

Alerts

Be the first to know and let us send you an email when North American Neuroendocrine Tumor Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to North American Neuroendocrine Tumor Society:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

North American Neuroendocrine Tumor Society

The North American Neuroendocrine Tumor Society (NANETS) is a society of over 400 multidisciplinary medical professionals committed to the support of the medical community in treating neuroendocrine tumor (NET) patients, as well as furthering NET science and education in North America.

NANETS is the only organization in the U.S. that offers comprehensive, accredited medical education programs on NET disease that are developed by leading NET experts and designed exclusively for medical professionals. The NANETS community is actively engaged in research, consensus guidelines, education and mentoring of young professionals.

NANETS has provided research grants, travel grants and education grants. NANETS also publishes an annual abstract book and seeks to publish abstracts and guidelines in major medical journals.